[Federal Register Volume 88, Number 77 (Friday, April 21, 2023)]
[Notices]
[Pages 24619-24620]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-08469]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Advisory Council on Alzheimer's Research, Care, and Services; 
Meeting

AGENCY: Assistant Secretary for Planning and Evaluation, HHS.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: This notice announces the public meeting of the Advisory 
Council on Alzheimer's Research, Care, and Services (Advisory Council). 
The Advisory Council provides advice on how to prevent or reduce the 
burden of Alzheimer's disease and related dementias (ADRD) on people 
with the disease and their caregivers. During the meeting on May 8, 
2023, the Advisory Council will hear presentations about the drug 
approval and coverage decision processes. A panel will also present on 
progress and challenges in translating research into clinical impact. 
Federal agencies will provide updates on activities during the last 
quarter.

DATES: The meeting will be held on May 8th from 9:30 p.m. to 4:30 p.m. 
EST.

ADDRESSES: The meeting will be a hybrid of in-person and virtual. The 
meeting will be held in Room 305A of the Hubert H. Humphrey Building, 
200 Independence Avenue SW, Washington, DC 20201. It will also stream 
live at www.hhs.gov/live.
    Comments: Time is allocated on the agenda to hear public comments 
from 4:00 p.m. to 4:30 p.m. The time for oral comments will be limited 
to two (2) minutes per individual. In order to provide a public 
comment, please register by emailing your name to [email protected] by 
Thursday, May 4th. Registered commenters will receive both a dial-in 
number and a link to join the meeting virtually; individuals will have 
the choice to either join virtually via the link, or to call in only by 
using the dial-in number. Note: There may be a 30-45 second delay in 
the livestream video presentation of the conference. For this reason, 
if you have pre-registered to submit a public comment, it is important 
to connect to the meeting by 3:45 p.m. to ensure that you do not miss 
your name and allotted time when called. You will not be admitted into 
the meeting before 3:45 p.m. If you miss your name and allotted time to 
speak, you may not be able to make your public comment. Should you have 
questions during the session email [email protected] and someone will 
respond to your message as quickly as possible.
    In order to ensure accuracy, please submit a written copy of oral 
comments for the record by emailing [email protected] by Tuesday, May 9, 
2023. These comments will be shared on the website and reflected in the 
meeting minutes.
    In lieu of oral comments, formal written comments may be submitted 
for the record by Tuesday, May 9, 2023 to Helen Lamont, Ph.D., OASPE, 
200 Independence Avenue SW, Room 424E, Washington, DC 20201. Comments 
may also be sent to [email protected]. Those submitting written comments 
should identify themselves and any relevant organizational 
affiliations.

FOR FURTHER INFORMATION CONTACT: Helen Lamont, 202-260-6075, 
[email protected]. Note: The meeting will be available to the public 
live at www.hhs.gov/live. Note: Seating

[[Page 24620]]

is very limited and will be limited to 10 members of the public. Those 
wishing to attend the meeting must send an email to [email protected] and 
put ``May 8 Meeting Attendance'' in the subject line so that their 
names may be put on a list of expected attendees and forwarded to the 
security officers at the Department of Health and Human Services. Any 
interested member of the public who is a non-U.S. citizen should 
include this information at the time of registration to ensure that the 
appropriate security procedure to gain entry to the building is carried 
out. Although the meeting is open to the public, procedures governing 
security and the entrance to Federal buildings may change without 
notice. If you wish to make a public comment, you must note that within 
your email.

SUPPLEMENTARY INFORMATION: Notice of these meetings is given under the 
Federal Advisory Committee Act (5 U.S.C. app. 2, section 10(a)(1) and 
(a)(2)). Topics of the Meeting: clinical care, dementia risk reduction, 
social determinants of health.
    Procedure and Agenda: The meeting will be webcast at www.hhs.gov/live and video recordings will be added to the National Alzheimer's 
Project Act website when available, after the meeting.
    Authority: 42 U.S.C. 11225; section 2(e)(3) of the National 
Alzheimer's Project Act. The panel is governed by provisions of Public 
Law 92-463, as amended (5 U.S.C. appendix 2), which sets forth 
standards for the formation and use of advisory committees.

    Dated: April 6, 2023.
Miranda Lynch-Smith,
Senior Official Performing the Duties of the Assistant Secretary for 
Planning and Evaluation Deputy Assistant Secretary for Human Services 
Policy.
[FR Doc. 2023-08469 Filed 4-20-23; 8:45 am]
BILLING CODE 4150-05-P